Antoine Lacombe

Risk-!n

[Antoine Lacombe @antoinelacombe1]

@MariaFleseriu @EsePresident @pituitaryorg @AcroCommunity Join the debate, bring your patients cases for discussion

[Dr. Maria Fleseriu @MariaFleseriu]

Together with Prof Giustina @EsePresident and our amazing speakers, we invite you to a new #Pituitary Webinar. Please send us your cases and join us for formal talks & an interactive discussion on #COVID19 & #acromegaly, #Cushing's #Pituitary #tumors @pituitaryorg @AcroCommunity

[Dr. Maria Fleseriu @MariaFleseriu]

#Survey on #acromegaly management in #COVID19 era for physicians and patients! @EsePresident #Endocrinologists links here https://t.co/KkCicZDBub, #neurosurgeons here https://t.co/opm4RDJGv1
@PituitarySoc @Pituitary_org @pituitaryorg @WAPO_org @PituitaryWNews @AcroCommunity

[HCC CONNECT powered by COR2ED @hccconnectinfo]

Dr Walid Ayoub provided a great overview of key abstracts from #AASLD19 about the screening of patients for #Hepatocellularcarcinoma and identified risk factors influencing #livercancer. Visit the link below and download the slides. #MedEd #oncology #HCC https://t.co/38QJfAzI4J

[GU CONNECT powered by COR2ED @guconnectinfo]

Prof. Sandy Srinivas provides a great overview of key abstracts from #ASCO2020. Click on the link, watch the video and download the slides here: https://t.co/fdQAqNV9Bg #oncology #MedEd

[Antoine Lacombe @antoinelacombe1]

@MariaFleseriu @ESEndocrinology Thanks @Isicy31 it was a pleasure to have you at #pituitary #pituitarymasterclass Great educational content from the master class will be available very soon

[Dr. Maria Fleseriu @MariaFleseriu]

Thank you! Glad you enjoyed it, please share your thoughts how to improve it even further in the future and email us with any questions. In addition to endocrinology courses, specialized one, ex #Pituitary play an important role.Good luck in your career! @ESEndocrinology

[Antoine Lacombe @antoinelacombe1]

Great talk from ⁦@MariaFleseriu⁩ at #pituitary #pituitarymasterclass stay tuned for the slides on download soon at https://t.co/zJVl997Fm4 ⁦@EsePresident⁩

[Antoine Lacombe @antoinelacombe1]

@MariaFleseriu @AcroCommunity @OHSUBrain @EsePresident @MariaFleseriu it is such a pleasure to have you with us

[Dr. Maria Fleseriu @MariaFleseriu]

Acromegaly “crew”, such a good session on #guidelines (and yes our new #JCEM paper came up) #tumor shrinkage &#diabetes. Great questions& discussion, indeed #Masterclass . New group selfie, getting pretty good. ⁦⁦@AcroCommunity⁩ ⁦@OHSUBrain⁩ ⁦@EsePresident⁩

[Antoine Lacombe @antoinelacombe1]

@UKMarkey @AmanChauhanMD Well done @AmanChauhanMD

[COR2ED @COR2EDMedEd]

Positive data on #PARPinhibitors is expected in various therapeutic areas, incl. PROfound, PRIMA and PAOLA-1.
Watch this short video to gain further insight into the #MoA of PARP inhibitors @ https://t.co/1Gue4YFu4S #DDR #parpi

[Abdelali (Ali) Majdi, MD @alitimumab]

Detecting Circulating Tumor Cells Through the Skin | Cancer Biomarkers | JAMA | JAMA Network https://t.co/cXsoFPgnvm

[Antoine Lacombe @antoinelacombe1]

#riskin19 people remain at the heart of risk management

[David Stewart 🏴󠁧󠁢󠁳󠁣󠁴󠁿 🇵🇹 @ds_caldas]

Looking forward to this presentation @Risk_in_Europe

[Anna Murray @apmurray123]

Risk-!N #Conference, Basel Switzerland
If you have yet to schedule your conferences for 2019, I will be speaking on a panel entitled #Cybersecurity, #Data Leaks, and #crimeware stories in May. Link to the event and more information here: https://t.co/OIfHkTEU4v

[NET CONNECT powered by COR2ED @net_connectinfo]

Dr. Elettra Merola and Dr. Kira Oleinikov have summarised highlights of the recent #ENETS19 for you @ https://t.co/Jq8FrRCS6Y @net_connectinfo #NETCancer #NeuroendocrineCancer #NeuroendocrineTumors

[GI CONNECT powered by COR2ED @giconnectInfo]

Dr. Matthew Matasar provides an update on follicular lymphoma @ https://t.co/q6OHgJTyzh #FollicularLymphoma